Genipin inhibits the growth of human bladder cancer cells via inactivation of PI3k/AkT signaling

Oncology Letters

Volumn 15, Issue 2, 2018, Pages 2619-2624

  Li, Zheng ^a   Zhang, Tian Biao ^b   Jia, Dong Hui ^b   Sun, Wen Qi ^a   Wang, Chao Liang ^b   Gu, Ao Zheng ^a   Yang, Xiao Ming ^b  

^a Nanyang Central Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; Bladder cancer; Cell cycle arrest; Growth; Natural compound

Indexed keywords

CYCLIN D1; CYCLIN D2; CYTOCHROME C; GENIPIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL TRAIT; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL VIABILITY ASSAY; CHEMILUMINESCENCE IMMUNOASSAY; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; DRUG INACTIVATION; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KNOWLEDGE; MALE; MICROSCOPY; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NONHUMAN; PI3K/AKT SIGNALING; PRACTICE GUIDELINE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT;

EID: 85038442331     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2017.7588     Document Type: Article

References (27)

1. Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S and Lotan Y: Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63: 234-241, 2013.
2. Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z and Salehiniya H: Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pac J Cancer Prev 17: 381-386, 2016.
3. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136: E359-E386, 2015.
4. Li S, Zeng XT, Ruan XL, Wang XH, Guo Y and Yang ZH: Simultaneous transurethral resection of bladder cancer and prostate may reduce recurrence rates: A systematic review and meta-analysis. Exp Ther Med 4: 685-692, 2012.
5. Vinall RL, Tepper CG, Ripoll AA, Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, Ghosh PM and deVere White RW: Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy. Genes Cancer 7: 86-97, 2016.
6. Cirone P, Andresen CJ, Eswaraka JR, Lappin PB and Bagi CM: Patient-derived xenografts reveal limits to PI3K/mTOR-and MEK-mediated inhibition of bladder cancer. Cancer Chemother Pharmacol 73: 525-538, 2014.
7. Wang Y, Leng H, Chen H, Wang L, Jiang N, Huo X and Yu B: Knockdown of UBE2T inhibits osteosarcoma cell proliferation, migration, and invasion by suppressing the PI3K/Akt signaling pathway. Oncol Res 24: 361-369, 2016.
8. Dong Q, Fu L, Zhao Y, Tan S and Wang E: Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling. Oncotarget 8: 17059-17069, 2017.
9. Alayev A, Salamon RS, Schwartz NS, Berman AY, Wiener SL and Holz MK: Combination of rapamycin and resveratrol for treatment of bladder cancer. J Cell Physiol 232: 436-446, 2017.
10. Nam KN, Choi YS, Jung HJ, Park GH, Park JM, Moon SK, Cho KH, Kang C, Kang I, Oh MS and Lee EH: Genipin inhibits the inflammatory response of rat brain microglial cells. Int Immunopharmacol 10: 493-499, 2010.
11. Wang GF, Wu SY, Rao JJ, Lü L, Xu W, Pang JX, Liu ZQ, Wu SG and Zhang JJ: Genipin inhibits endothelial exocytosis via nitric oxide in cultured human umbilical vein endothelial cells. Acta Pharmacol Sin 30: 589-596, 2009.
12. Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, Lin CT, Porco JA Jr and Lowell BB: Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab 3: 417-427, 2006.
13. Suzuki Y, Kondo K, Ikeda Y and Umemura K: Antithrombotic effect of geniposide and genipin in the mouse thrombosis model. Planta Med 67: 807-810, 2001.
14. Hughes RH, Silva VA, Ahmed I, Shreiber DI and Morrison B III: Neuroprotection by genipin against reactive oxygen and reactive nitrogen species-mediated injury in organotypic hippocampal slice cultures. Brain Res 1543: 308-314, 2014.
15. Wang N, Zhu M, Tsao SW, Man K, Zhang Z and Feng Y: Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma. PLoS One 7: e46318, 2012.
16. Wang R, MoYung KC, Zhao YJ and Poon K: A mechanism for the temporal potentiation of genipin to the cytotoxicity of cisplatin in colon cancer cells. Int J Med Sci 13: 507-516, 2016.
17. Perelman A, Wachtel C, Cohen M, Haupt S, Shapiro H and Tzur A: JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis 3: e430, 2012.
18. Singh AN, Baruah MM and Sharma N: Structure Based docking studies towards exploring potential anti-androgen activity of selected phytochemicals against Prostate Cancer. Sci Rep 7: 1955, 2017.
19. Koo HJ, Song YS, Kim HJ, Lee YH, Hong SM, Kim SJ, Kim BC, Jin C, Lim CJ and Park EH: Antiinflammatory effects of genipin, an active principle of gardenia. Eur J Pharmacol 495: 201-208, 2004.
20. Cao H, Feng Q, Xu W, Li X, Kang Z, Ren Y and Du L: Genipin induced apoptosis associated with activation of the c-Jun NH2-terminal kinase and p53 protein in HeLa cells. Biol Pharm Bull 33: 1343-1348, 2010.
21. Ko H, Kim JM, Kim SJ, Shim SH, Ha CH and Chang HI: Induction of apoptosis by genipin inhibits cell proliferation in AGS human gastric cancer cells via Egr1/p21 signaling pathway. Bioorg Med Chem Lett 25: 4191-4196, 2015.
22. Feng Q, Cao HL, Xu W, Li XR, Ren YQ and Du LF: Apoptosis induced by genipin in human leukemia K562 cells: Involvement of c-Jun N-terminal kinase in G2/M arrest. Acta Pharmacol Sin 32: 519-527, 2011.
23. Coqueret O: New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment? Trends Cell Biol 13: 65-70, 2003.
24. Pastorino JG, Chen ST, Tafani M, Snyder JW and Farber JL: The overexpression of bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 273: 7770-7775, 1998.
25. Yang X, Yao J, Luo Y, Han Y, Wang Z and Du L: P38 MAP kinase mediates apoptosis after genipin treatment in non-small-cell lung cancer H1299 cells via a mitochondrial apoptotic cascade. J Pharmacol Sci 121: 272-281, 2013.
26. Qin J, Xie LP, Zheng XY, Wang YB, Bai Y, Shen HF, Li LC and Dahiya R: A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun 354: 852-857, 2007.
27. Kim MS, Kim JE, Lim DY, Huang Z, Chen H, Langfald A, Lubet RA, Grubbs CJ, Dong Z and Bode AM: Naproxen induces cell-cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3K. Cancer Prev Res (Phila) 7: 236-245, 2014.